`
`John R. Plachetka, Pharm.D. | President, Chief Executive Officer and Chairman | Transforming medicine. Transforming lives. | POZEN
`
`search...
`ABOUT » PRODUCTS » INVESTORS » MEDIA » CORPORATE GOVERNANCE » BUSINESS DEVELOPMENT » CONTACT
`
`ABOUT
`
`About POZEN
`Executive Officer Bios
`Board of Directors
`Culture
`Careers
`FAQ
`
`JOHN R. PLACHETKA
`
`John R. Plachetka, Pharm.D., is President, Chief Executive Officer and Chairman of the Board of Directors of
`POZEN.
`
`Prior to founding POZEN in 1996, Dr. Plachetka was Vice President of Development at Texas Biotechnology
`Corporation for two years, where he led the development of argatroban, a novel thrombin blocker. Previously, he
`served for two years as President and Chief Executive Officer of Clinical Research FoundationAmerica, a top10
`contract clinical research company in the U.S. This was preceded by a nineyear career at Glaxo Inc. where Dr.
`Plachetka held various executive positions including Director of Cardiovascular Clinical Research and led the U.S.
`development program for Imitrex®, Trandate®, and a thromboxane antagonist. He also participated in the
`development program for Zantac® tablets and injection.
`
`Dr. Plachetka was formerly assistant professor of Pharmacy Practice and Cardiovascular and Thoracic Surgery at the University of
`Arizona. He earned his bachelor’s degree in pharmacy from the University of Illinois College of Pharmacy and holds a doctor of
`pharmacy degree from the University of MissouriKansas City.
`
`Back to Executive Team
`
`All contents © 20052015 POZEN Inc. All Rights Reserved » Terms and Conditions » Site Map
`
`http://www.pozen.com/about/johnplachetka/
`
`1/1
`
`Lupin Exh. 1020